Tonix Pharmaceuticals Holding Corp. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD for Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate for Q2 2024.
  • Tonix Pharmaceuticals Holding Corp. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2024 was $3.34M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.34M Jun 30, 2024 10-Q 2024-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.